Mission BioCapital

Mission BioCapital is a venture capital firm focused on making pivotal early-stage investments in life sciences companies. The firm supports its portfolio companies through a unique combination of shared lab space, capital investment, and access to strategic partners. With offices in leading life sciences clusters in Cambridge, Massachusetts, and San Francisco, California, Mission BioCapital is dedicated to helping entrepreneurial scientists build successful companies, from idea to exit.

In addition to its investment activities, Mission BioCapital established the Platinum Program in 2022 to fast-track high-potential life sciences start-ups. The program offers pre-seed funding, lab space, expert mentorship, and discovery services to accelerate the launch and development of innovative companies. Winners of the Platinum Program are eligible for lab space at MBC's partner incubators in the U.S. and Europe, access to world-class experts, and seed capital to develop scientific data needed for subsequent funding rounds.

The firm has expanded its European presence by establishing an office and incubator partnership at the BioInnovation Institute in Copenhagen, Denmark. This expansion reflects Mission BioCapital's commitment to nurturing entrepreneurial bioscience across Europe and globally. Robert Blazej, PhD, Partner at Mission BioCapital, relocated to Copenhagen to launch the firm's European office, further strengthening its international footprint and support for life sciences innovation.